Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
about
Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16.Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-AnalysisEvaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
P2860
Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bacillus Calmette-Guérin (BCG) ...... d passive surveillance system.
@en
type
label
Bacillus Calmette-Guérin (BCG) ...... d passive surveillance system.
@en
prefLabel
Bacillus Calmette-Guérin (BCG) ...... d passive surveillance system.
@en
P2093
P2860
P1433
P1476
Bacillus Calmette-Guérin (BCG) ...... ed passive surveillance system
@en
P2093
Jim P Buttery
Julie-Ann Quinn
Laine Hosking
Mee Lee Easton
Nigel W Crawford
P2860
P2888
P356
10.1007/S40264-014-0248-6
P577
2015-01-01T00:00:00Z
P6179
1019706821